Tag Archives: Treatment

Cystic Acne Treatment: What’s Up With Those Large, Painful Pimples That Won’t Go Away? – Self

You’ve probably experienced a few different types of acne since your teenage years, from annoying blackheads to juicy papules. But if you’ve ever developed one of those large, deep, painful red pimples that doesn’t go away, and sometimes never comes to a head, you know it’s a different beast altogether.  If you’ve been slathering your… Read More »

Causes and treatment of vaginal cuts

Minor vaginal cuts and tears are common and often occur when a person is removing body hair or engaging in sexual activity. People with certain hormonal, skin, and immune conditions may be more likely to get vaginal cuts or tears. Minor vaginal wounds are usually harmless, but they may cause mild pain and discomfort for… Read More »

FDA Approves Expanded Monotherapy Label for Merck’s Keytruda (pembrolizumab) for First-Line Treatment of NSCLC

Print this page KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded label for Keytruda, Merck’s anti-PD-1 therapy, as monotherapy for the first-line treatment of patients with stage III non-small cell lung cancer (NSCLC) who are not… Read More »

FDA Approves Balversa (erdafitinib) for the Treatment of Metastatic Bladder Cancer

FDA Approves Balversa (erdafitinib) for the Treatment of Metastatic Bladder Cancer Print this page April 12, 2019 — The U.S. Food and Drug Administration today granted accelerated approval to Balversa (erdafitinib), a treatment for adult patients with locally advanced or metastatic bladder cancer that has a type of susceptible genetic alteration known as FGFR3 or… Read More »

FDA Approves Avaclyr (acyclovir ophthalmic ointment) for the Treatment of Herpetic Keratitis

FDA Approves Avaclyr (acyclovir ophthalmic ointment) for the Treatment of Herpetic Keratitis Print this page NEW YORK–(BUSINESS WIRE) April 01, 2019 –The US Food and Drug Administration (FDA) has approved Fera Pharmaceuticals’ New Drug Application (NDA) for Avaclyr (acyclovir ophthalmic ointment) 3% for the treatment of herpetic keratitis. Orphan drug exclusivity was also granted, providing… Read More »